Quotient Sciences Quotient Sciences

X

Digital content for Oncopeptides

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Oncopeptides
Sweden Flag
Country
Country
Sweden
Address
Address
Luntmakargatan 46, vån 7 SE-111 37 Stockholm
Telephone
Telephone
+46 8 615 20 40
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.pharmabiz.com/NewsDetails.aspx?aid=168217&sid=2

PHARMABIZ
30 Mar 2024

https://endpts.com/fda-formally-pulls-oncopeptides-cancer-drug-after-prolonged-back-and-forth/

ENDPTS
23 Feb 2024

https://endpts.com/cder-challenges-oncopeptides-appeal-over-pepaxto-withdrawal/

Lia DeGroot ENDPTS
13 Sep 2023

https://endpts.com/fda-publishes-oncopeptides-withdrawal-appeal-for-swedish-biotechs-cancer-drug-pepaxto/

Kyle LaHucik ENDPTS
25 Aug 2023

https://endpts.com/last-resort-oncopeptides-formally-challenges-fdas-withdrawal-of-cancer-drugs-accelerated-approval/

Zachary Brennan ENDPTS
11 Aug 2023

https://endpts.com/oncopeptides-says-swedish-authorities-ended-probe-into-cso-jakob-lindberg-over-alleged-insider-information-sharing/

Amber Tong ENDPTS
30 May 2023

https://endpts.com/oncopeptides-exec-is-arrested-in-sweden-for-allegedly-passing-insider-information/

Max Gelman ENDPTS
08 Mar 2023

https://www.prnewswire.com/news-releases/oncopeptides-chief-financial-officer-holger-lembrer-takes-office-today-301724362.html

PR NEWSWIRE
18 Jan 2023

https://endpts.com/oncopeptides-and-zymeworks-replace-execs/

Max Gelman ENDPTS
05 Jan 2023

https://www.prnewswire.com/news-releases/oncopeptides-provides-update-on-pepaxto-us-marketing-authorization-301697069.html

PRNEWSWIRE
07 Dec 2022
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY